Literature DB >> 7893140

Genetic variability of the human immunodeficiency virus: statistical and biological issues.

F Seillier-Moiseiwitsch1, B H Margolin, R Swanstrom.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7893140     DOI： 10.1146/annurev.ge.28.120194.003015

Source DB:  PubMed          Journal:  Annu Rev Genet        ISSN： 0066-4197            Impact factor:   16.830


× No keyword cloud information.
  15 in total

1.  Genetic variation and susceptibilities to protease inhibitors among subtype B and F isolates in Brazil.

Authors:  A Tanuri; A C Vicente; K Otsuki; C A Ramos; O C Ferreira; M Schechter; L M Janini; D Pieniazek; M A Rayfield
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

2.  Analysis of HIV-1 env gene sequences reveals evidence for a low effective number in the viral population.

Authors:  A J Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

3.  Sequence and drug susceptibility of subtype C reverse transcriptase from human immunodeficiency virus type 1 seroconverters in Zimbabwe.

Authors:  R W Shafer; J A Eisen; T C Merigan; D A Katzenstein
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

4.  Molecular epidemiology of HIV-1 infection in immigrant population in northern Italy.

Authors:  Caterina Sagnelli; Caterina Uberti-Foppa; Sabrina Bagaglio; Eleonora Cella; Vittoria Scolamacchia; Hamid Hasson; Stefania Salpietro; Emanuela Messina; Giulia Morsica; Silvia Angeletti; Massimo Ciccozzi; Adriano Lazzarin; Evangelista Sagnelli
Journal:  Epidemiol Infect       Date:  2020-02-05       Impact factor: 2.451

5.  Molecular Epidemiology of HIV-1 Virus in Puerto Rico: Novel Cases of HIV-1 Subtype C, D, and CRF-24BG.

Authors:  Pablo López; Omayra De Jesús; Yasuhiro Yamamura; Nayra Rodríguez; Andrea Arias; Raphael Sánchez; Yadira Rodríguez; Vivian Tamayo-Agrait; Wilfredo Cuevas; Vanessa Rivera-Amill
Journal:  AIDS Res Hum Retroviruses       Date:  2018-05-23       Impact factor: 2.205

6.  Characterization of human immunodeficiency virus type 1 in saliva and blood plasma by V3-specific heteroduplex tracking assay and genotype analyses.

Authors:  S A Freel; J M Williams; J A Nelson; L L Patton; S A Fiscus; R Swanstrom; D C Shugars
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

7.  Mechanisms of human immunodeficiency virus Type 1 (HIV-1) neutralization: irreversible inactivation of infectivity by anti-HIV-1 antibody.

Authors:  J S McDougal; M S Kennedy; S L Orloff; J K Nicholson; T J Spira
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

8.  Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants.

Authors:  L H Ping; J A Nelson; I F Hoffman; J Schock; S L Lamers; M Goodman; P Vernazza; P Kazembe; M Maida; D Zimba; M M Goodenow; J J Eron; S A Fiscus; M S Cohen; R Swanstrom
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

Review 9.  The optimization of helper T lymphocyte (HTL) function in vaccine development.

Authors:  J Alexander; J Fikes; S Hoffman; E Franke; J Sacci; E Appella; F V Chisari; L G Guidotti; R W Chesnut; B Livingston; A Sette
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

10.  Transitions to and from the CD4-bound conformation are modulated by a single-residue change in the human immunodeficiency virus type 1 gp120 inner domain.

Authors:  Aemro Kassa; Navid Madani; Arne Schön; Hillel Haim; Andrés Finzi; Shi-Hua Xiang; Liping Wang; Amy Princiotto; Marie Pancera; Joel Courter; Amos B Smith; Ernesto Freire; Peter D Kwong; Joseph Sodroski
Journal:  J Virol       Date:  2009-06-17       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.